Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BONE DENSITY CONSERVATION AGENTS - ADVERSE EFFECTS , . Treffer: 24

2017

Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, AD; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
Arch Osteoporos. 2017; 12(1):58-58 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Khan, AA; Morrison, A; Kendler, DL; Rizzoli, R; Hanley, DA; Felsenberg, D; McCauley, LK; O'Ryan, F; Reid, IR; Ruggiero, SL; Taguchi, A; Tetradis, S; Watts, NB; Brandi, ML; Peters, E; Guise, T; Eastell, R; Cheung, AM; Morin, SN; Masri, B; Cooper, C; Morgan, SL; Obermayer-Pietsch, B; Langdahl, BL; Dabagh, RA; Davison, KS; Sándor, GK; Josse, RG; Bhandari, M; El Rabbany, M; Pierroz, DD; Sulimani, R; Saunders, DP; Brown, JP; Compston, J; International Task Force on Osteonecrosis of the Jaw Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.
J Clin Densitom. 2016; 20(1):8-24
Web of Science PubMed FullText FullText_MUG

 

Svejda, B; Muschitz, Ch; Gruber, R; Brandtner, Ch; Svejda, Ch; Gasser, RW; Santler, G; Dimai, HP [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Wien Med Wochenschr. 2016; 166(1-2):68-74 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Assaf, AT; Zrnc, TA; Remus, CC; Adam, G; Zustin, J; Heiland, M; Friedrich, RE; Derlin, T Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
J Craniomaxillofac Surg. 2015; 43(8):1461-1469
Web of Science PubMed FullText FullText_MUG

 

Hadji, P; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Zhang, E; Frieling, I; Geusens, P; Makras, P; Resch, H; Möller, G; Kalouche-Khalil, L; Fahrleitner-Pammer, A Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015; 26(10):2479-2489 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rugani, P; Kirnbauer, B; Acham, S; Truschnegg, A; Jakse, N Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
J Oral Implantol. 2015; 41 Spec No:377-381
Web of Science PubMed FullText FullText_MUG

 

2014

Jacobsen, C; Zemann, W; Obwegeser, JA; Grätz, KW; Metzler, P The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.
Oral Maxillofac Surg. 2014; 18(1):31-37
PubMed FullText FullText_MUG

 

Roux, C; Hofbauer, LC; Ho, PR; Wark, JD; Zillikens, MC; Fahrleitner-Pammer, A; Hawkins, F; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Bone. 2014; 58(2):48-54 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Lung, S; Resch, H Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density.
J Bone Miner Res. 2013; 28(1):196-205 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Boonen, S; Reginster, JY; Kaufman, JM; Lippuner, K; Zanchetta, J; Langdahl, B; Rizzoli, R; Lipschitz, S; Dimai, HP; Witvrouw, R; Eriksen, E; Brixen, K; Russo, L; Claessens, F; Papanastasiou, P; Antunez, O; Su, GQ; Bucci-Rechtweg, C; Hruska, J; Incera, E; Vanderschueren, D; Orwoll, E; Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis.
N ENGL J MED. 2012; 367(18): 1714-1723. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jacobsen, C; Metzler, P; Obwegeser, JA; Zemann, W; Graetz, KW Osteopathology of the jaw associated with bone resorption inhibitors: what have we learned in the last 8 years?
Swiss Med Wkly. 2012; 142(5):w13605-w13605 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Muschitz, C; Fahrleitner-Pammer, A; Huber, J; Preisinger, E; Kudlacek, S; Resch, H Update on denosumab in postmenopausal osteoporosis--recent clinical data.
Wien Med Wochenschr. 2012; 162(17-18):374-379
PubMed FullText FullText_MUG

 

2011

Zittermann, A; Pilz, S; Börgermann, J; Gummert, JF Calcium supplementation and vitamin D: a trigger for adverse cardiovascular events?
Future Cardiol. 2011; 7(6): 725-727. [OPEN ACCESS]
PubMed FullText FullText_MUG

 

2010

Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR) Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Wien Med Wochenschr. 2010; 160(21-22):586-589
PubMed FullText FullText_MUG

 

Rugani, P; Acham, S; Truschnegg, A; Obermayer-Pietsch, B; Jakse, N Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110(6):e1-e6 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2009

Cummings, SR; San Martin, J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; FREEDOM Trial Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
N Engl J Med. 2009; 361(8): 756-765. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR) Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009
Wien Med Wochenschr Suppl. 2009; (122): 1-34.
PubMed FullText FullText_MUG Google Scholar

 

Eastell, R; Nickelsen, T; Marin, F; Barker, C; Hadji, P; Farrerons, J; Audran, M; Boonen, S; Brixen, K; Gomes, JM; Obermayer-Pietsch, B; Avramidis, A; Sigurdsson, G; Glüer, CC Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS).
J Bone Miner Res. 2009; 24(4): 726-736. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Obermayer-Pietsch, BM; Marin, F; McCloskey, EV; Hadji, P; Farrerons, J; Boonen, S; Audran, M; Barker, C; Anastasilakis, AD; Fraser, WD; Nickelsen, T Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.
J BONE MINER RES. 2008; 23(10): 1591-1600. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Egner-Höbarth, S; Welkerling, H; Windhager, R Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects
Orthopade. 2007; 36(2): 126- 130.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Stepan, JJ; Burr, DB; Pavo, I; Sipos, A; Michalska, D; Li, J; Fahrleitner-Pammer, A; Petto, H; Westmore, M; Michalsky, D; Sato, M; Dobnig, H Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.
Bone. 2007; 41(3): 378-385.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Topakian, R; Stieglbauer, K; Rotaru, J; Haring, HP; Aichner, FT; Pichler, R Hypocalcemic choreoathetosis and tetany after bisphosphonate treatment.
Mov Disord. 2006; 21(11):2026-2027 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

© Meduni Graz Impressum